측면형과 다른 임상형의 원위외측손발톱밑 손발톱진균증의 치료효과의 차이에 대한 연구
Comparison of Therapeutic Efficacy between Lateral Type of Distal and Lateral Subungual Onychomycosis (DLSO) and Non-lateral Types of DLSO
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Onychomycosis is a common fungal infection accounting for 50% of all nail disorders. Above all the clinical types of onychomycosis, distal and lateral subungual onychomycosis (DLSO) is the most common clinical type seen up to 70~90% in onychomycosis patients. Even though the cure rate and recurrence rate of DLSO are considered to be different according to the clinical type of DLSO. Clinical experience, there is a few clinical study showing the difference. Objectives: This is to investigate the therapeutic efficacy of lateral type of DLSO comparing with the other types of DLSO. Methods: We reviewed 81 DLSO cases who visited our clinic from June 1st, 2006 to June 31st, 2010,and classified them into 2 groups; lateral type and non-lateral types including edge, distal and linear type. We treated the patients with oral antifungal agent for 4 months, and followed them up in 2 months. Scoring clinical index for onychomycosis (SCIO) was checked and photography was taken before treatment and after treatment. Results: There are no significant differences in average age and male to female ratio between lateral DLSO and non-lateral DLSO. The comparison of SCIO score distribution before treatment between lateral DLSO and non-lateral DLSO showed no significant statistical difference. However, there was significant change in SCIO score distribution after the treatment. Decreased SCIO score in lateral DLSO was 6.99, while non-lateral DLSO was 11.1 (p=0.018). There was 2cases worsen cases in lateral DLSO, while there was no worsen case in non-lateral DLSO (p=0.019). Conclusion: Lateral DLSO is more difficult to treat than non-lateral DLSO.
Abstract
Background: Onychomycosis is a common fungal infection accounting for 50% of all nail disorders. Above all the clinical types of onychomycosis, distal and lateral subungual onychomycosis (DLSO) is the most common clinical type seen up to 70~90% in onychomycosis patients. Even though the cure rate and recurrence rate of DLSO are considered to be different according to the clinical type of DLSO. Clinical experience, there is a few clinical study showing the difference. Objectives: This is to investigate the therapeutic efficacy of lateral type of DLSO comparing with the other types of DLSO. Methods: We reviewed 81 DLSO cases who visited our clinic from June 1st, 2006 to June 31st, 2010,and classified them into 2 groups; lateral type and non-lateral types including edge, distal and linear type. We treated the patients with oral antifungal agent for 4 months, and followed them up in 2 months. Scoring clinical index for onychomycosis (SCIO) was checked and photography was taken before treatment and after treatment. Results: There are no significant differences in average age and male to female ratio between lateral DLSO and non-lateral DLSO. The comparison of SCIO score distribution before treatment between lateral DLSO and non-lateral DLSO showed no significant statistical difference. However, there was significant change in SCIO score distribution after the treatment. Decreased SCIO score in lateral DLSO was 6.99, while non-lateral DLSO was 11.1 (p=0.018). There was 2cases worsen cases in lateral DLSO, while there was no worsen case in non-lateral DLSO (p=0.019). Conclusion: Lateral DLSO is more difficult to treat than non-lateral DLSO.
참고문헌 (23)
- Welsh O, "Onychomycosis", Clin Dermatol, 28, pp.151~159 (2010)
- Zaias N, "Onychomycosis", Arch Dermatol, 105, pp.263~274 (1972)
- 안효상, "한국인 손발톱진균증의 임상적 분류", 대한의진균학회지, 13(3), pp.129~137 (2008), 대한의진균학회1
- Effendy I, "Epidemiology and clinical classification of onychomycosis", J Eur Acad Dermatol Venerol, 19(1), pp.8~12 (2005)
- Suh MK, "Treatment and prophylaxis of onychomycosis", Kor J Med Mycol, 6, pp.140~142 (2001)
- Hay RJ, "A proposed revision of the clinical classification", J Am Acad Dermatol (2011)
- Virendra NS, "Onychomycosis: A 3-year clinicomycologic hospital-based study", Skinmed, 6, pp.11~17 (2007)
- 김덕한, "조갑진균증의 임상적 고찰 : 조갑진균증의 치료에 영향을 주는 인자와 그에 따른 치유율 비교", 대한의진균학회지, 10(2), pp.55~69 (2005), 대한의진균학회1
- 오대헌, "선형 조갑진균증의 발생 요인과 치료 반응에 대한 연구", 대한의진균학회지, 10(1), pp.21~29 (2005), 대한의진균학회1
- Baran R, "Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals", Acta Derm Venereol, 76, pp.82~83 (1996)
- Sergeev AY, "The scoring clinical index for onychomcyosis (SCIO index)", Skin Therapy Lett, 7, pp.S6~S7 (2002)
- Scher RK, "Onychomycosis: diagnosis and definition of cure", J Am Acad Dermatol, 56, pp.939~944 (2007)
- Elewski BE, "Onychomycosis: pathogenesis, diagnosis, and management", Clin Microbiol Rev, 11, pp.415~ (1998)
- Arrese JE, "Treatment failures and relapses in onychomycosis: a stubborn clinical problem", Dermatology, 207, pp.255~260 (2003)
- Sommer S, "Prediction of outcome in the treatment of onychomycosis", Clin Exp Dermatol, 28, pp.425~428 (2003)
- Sigurgeirsson B, "Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents", Br J Dermatol, 147, pp.1241~1243 (2002)
- 조소연, "조갑진균증 치료와 재발에 관련된 인자들", 대한의진균학회지, 16(1), pp.9~15 (2011), 대한의진균학회1
- Sigurgeirsson B, "Prognostic factors for cure following treatment of onychomycosis", J Eur Acad Dermatol Venereol, 24, pp.679~684 (2010)
- Scher RK, "Onychomycosis in clinical practice: factors contributing to recurrence", Br J Dermatol, 149(65), pp.5~9 (2003)
- Evans EG, "Causative pathogens in onychomycosis and the possibility of treatment resistance", J Am Acad Dermatol, 38, pp.S32~S36 (1998)
- Baran R, "A new classification of onychomycosis", Br J Dermatol, 139, pp.567~571 (1998)
- 김영식, "경구항진균제, Nail Lacquer 국소도포와 함께 손발톱 밑으로 항진균제를 직접 주입하여 완치를 보인 피부사상균종 (Dermatophytoma)를 동반한 손발톱진균증", 대한의진균학회지, 15(3), pp.146~149 (2010), 대한의진균학회1
- Sumikawa M, "Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis", J Dermatol, 34, pp.456~464 (2007)